EMA - Global regulators discuss path towards regulatory alignment on response to Omicron variant

25th January 2022

On 12 January, regulators from around the world discussed the global regulatory response to the COVID-19 Omicron variant during a workshop, co-chaired by the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).

Read More

Back to News Archive